10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image Guided Therapy May 12, 13, 14, 2013 Society for Brain Mapping and Therapeuticst - ShBMT Annual world Congressof 10   Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare  Policy SBMT on Brain, Cord Mapping and Breaking Boundaries of Science, Technology, Society for Brain Mapping and Therapeutics - SBMT  Medicine, Art and Healthcare Policy  THEME: NANO-BIO-ELECTRONICS May 12, 13, Baltimore Convention Center, 14, 2013 Baltimore, Maryland    United States of America              www.worldbrainmapping.org 1 th 10 Annual world Congress     of SBMT on Brain, Cord Mapping and Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy  INFO Society for Brain Mapping and Therapeutics - SBMT SBMT Global Headquarters C 8159 Santa Monica Blvd., Suite 200 ontents West Hollywood, CA 90046   Tel: 310.500.6196 Fax: 323.654.3511 SBMT (Mission statement, Educational objectives, [email protected] Annual world congress, Congress chairs, Charter.)...............p. 3-4 WorldBrainMapping.org Continuing Medical Education need assessment ...................p.5 CME ACCREDITATION Continuing Medical Education disclosures.................p.6-8 Society Board of Directors.............p.10-11 Scientific Committee............p.12-15 Accreditation/designation  Statement:   SBMT Letter from the Founder............p.16-17 (Babak Kateb) This activity has been planned  and  implemented  in  accor‐ SBMT President address..................p.18 dance with the Essential Ar‐ (Kuldip Sidhu) eas  and  policies  of  the  Ac‐ creditation  Council  for  Con‐ SBMT Program …....... p.19-21 tinuing  Medical  Education  Keynote speakers .......... p.22-26 through the joint sponsorship  of  the  International  Society  Timetable ............p.27-29 for  Magnetic  Resonace  in  Sunday May 12 - Scientific program ...........p.30-36 Medicine  (ISMRM)  and  the  Society for Brain Mapping &  Monday May 13 - Scientific program .......... p.37-47 Therapeutics  (SBMT).  The  Tuesday, May 14 - Scientific program …...... p.48-56 ISMRM) is accredited by the  ACCME to provide continuing  Oral poster and Posters ......... p. 47-59 medical education for physi‐ Faculty .......... p.59-66 cians.  Sponsors & Exhibitors .................p.67 The International Society for  Gala Reception - Awards .......... p.68-70 Magnetic Resonance in Medi‐ cine (ISMRM) designates this  11th Annual world Congress, Sydney Australia...….……..p. 71 live activity for a maximum of  9.50  AMA  PRA  Category  1  Credit(s)™. Physicians should  claim  only  the  credit  com‐ mensurate with the extent of 10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image Guided Therapy May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy SBMT Mission Statement SBMT is a non-profit society organized for the purpose of encouraging basic and clinical scientists who are interested in areas of Brain Mapping, engineering, stem cell, nanotechnology, imaging and medical device to improve the diagnosis, treatment and rehabilitation of patients afflicted with neurological disorders. This society promotes the public welfare and improves patient care through the translation of new technologies/therapies into life saving diagnostic and therapeutic procedures. The society is com- mitted to excellence in education, and scientific discovery. The society achieves its mission through multi-disciplinary collaborations with government agencies, patient advocacy groups, edu- cational institutes and industry as well as philanthropic organization. Educational Objectives Upon completion of the scientific meeting, participants should be able to:  Identify new findings in brain mapping (BM) & intraoperative surgical planning (ISP) most relevant to their own sub field (i.e. molecular imaging and or biophotonics);  Describe the effect of the newly developed methods in medical imaging, medical devices, nanotechnology, stem cell/cellular therapy;  Discuss and design the possible future research and developments in BM, ISP and Nano-Bio-Electronics and assess the possible impact of such research and devel- opment on their own clinical and scientific work in the future;  Describe and assess the latest cutting-edge technological advancement in BM & ISP such as emerging field of nano-bio-electronics (integration of nanotechnology with stem cell/cellular therapy, medical imaging and medical devices);  Explain ways to build a bridge amongst multiple disciplines;  Educate the audience about the advancements in other disciplines and explain how such advancements could help them formulate new diagnostics and treatment mo- dalities; CONGRESS CHAIRS  Discuss and describe governmental agencies, founda- Babak Kateb tions, and industry roles in research and development of Michael J. Roy the field. Rafat Ansari Yu Chen ANNUAL SBMT WORLD CONGRESS James M. Ecklund Rao P. Gullapalli The Annual World Congress is a multi-disciplinary forum designed to James McDonald facilitate cross-pollination and dissemination of technological and medical advances and scientific discovery. The attendees are a mixture of neurosurgeons, radiologists, neurolo- gists, psychiatrists, rehabilitation medicine, cardiologists, oncologists, bioethicists, policy makers, government officials, engineers, physicists, neuroscience, stem cell scientists, Bio-technologists, nano technolo- 3 10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image Guided Therapy May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy CHARTER of SBMT The Society for Brain Mapping and Therapeutics (SBMT) was founded in   2004 to break boundaries in healthcare. The society promotes policies that support rapid, safe, and cost-effective translation of new technology into medicine. The SBMT globally promotes interdisciplinary research to improve the di- agnosis, treatment, and rehabilitation of patients with central nervous sys- tem diseases regardless of race, creed, color, national origin, gender, or age. The SBMT catalyzes interactions between clinical, biological, physical and engineering sciences. The Society builds transdisciplinary and translational consortia which break down traditional barriers that impede application of new technology to medical problems. Translational research applies cutting edge basic science and advanced technologies to clinical neurosciences. The Society examines emerging disciplines such as nanotechnology, image-guided therapy, stem cell ther- apy, multi-modality imaging, biophotonics, and biomaterial and tissue engi- neering for their application to the diagnosis, treatment, and rehabilitation from neurological diseases. The Society seeks to apply these technologies to clinical problems such as brain tumors, stroke, epilepsy, neurodegenera- tive diseases (Parkinson, Alzheimer, multiple sclerosis and ALS), traumatic brain and spinal cord injuries, autism, post traumatic stress disorder and other psychiatric illnesses. The Society achieves its goals through meetings, fellowships, publications, international collaborations, consortiums, and policy forums. The SBMT is a nonprofit society which has obtained support from many government agencies (USA, EU and Asia), foundations, and multi-national corpora- tions. The Society maintains its headquarters in West Hollywood, Califor- nia. 4 10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image Guided Therapy May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy CONTINUING MEDICAL EDUCATION In recent years astonishing advances have contributed to amazing CHAIR OF THE CME discoveries and breakthroughs in fields of neurology, neuroscience, COMMITTEE neurosurgery, radiology, engineering, computer science, nanotech- nology, medical imaging, medical devices and cellular/stem cell therapy. These scientific advances also have contributed to the large gap of knowledge amongst the scientists in different disciplines. One of the major challenges of 21st century for the scientific community is how to close such gaps of knowledge amongst multiple disciplines. We have designed the annual meeting of SBMT to address such Babak Kateb challenge by bringing together world class experts across multiple Chairman /CEO SBMT disciplines. & President of Brain Mapping Moreover, we have identified a need for progressive integration of Foundation nanotechnology, cellular therapy with medical devices and imaging. This is why we have chosen “Nano-Bio-Electronics” as the theme of the 10th Annual world Congress of SBMT in Baltimore, Maryland, USA. The purpose of the annual meeting is to create an interactive envi- ronment, which foster cross-pollination of ideas and pave the way for birth of new treatment and diagnostic modalities in the field.. - - - - - - - - - - - - - - - - - -   For questions about CME, please contact: Jacob Coverstone, Director of Education International Society for Magnetic Resonance in Medicine (ISMRM) & Section for Magnetic Resonance Technologists (SMRT) 2030 Addison Street, Suite 700 Berkeley, CA 94704 USA T: +1 510 841 1899 • F: +1 510 841 2340 • E: [email protected] 5 10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image Guided Therapy May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy CONTINUING MEDICAL EDUCATION (CME) Disclosure Information: The ISMRM and Society for Brain Mapping and Therapeutics con- trol the content and production of this CME activity and attempt to ensure the presentation of bal- anced, objective information. In accordance with the Standards for Commercial Support estab- lished by the Accreditation Council for Continuing Medical Education (ACCME), faculty, abstract reviewers, paper presenters/authors, planning committee members, staff and any others involved in planning the educational content and the significant others of those mentioned must disclose any relationship they or their co-authors have with commercial interests which may be related to their content. The ACCME defines "relevant financial relationships" as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. Those who have disclosed a relationship* with commercial interests are listed below: Name Type of Disclosures - What was Disclosed University Grants/Research Support - NINDS R21NS081416; Pending Allyson Rosen VA Merit 1I01CX000604-01, France-Stanford Grant Andreia Vaconcellos Faria GOVERNMENT FUNDING University Grants/Research Support Maxine Dunitz Neurosurgical Christopher J. Wheeler Inst., Cedars-Sinai Medical Center, Dept. of Neurosurgery; Joseph Drown Foundation Grant Cynthia Roberts Consultant Fee - Ziemer Ophthalmic Systems AG University Granst/Research Support: Telemedicinr and Advnaced Technology Research Center (TATRC) David F. Tate Consultant Fee: Brigham and Wmoen';s Hospital Employee: contractor for Henry M. Foundation for the Advancement of Military Medicine CONSULTANT -Codman & Shurtleff, Covidian ev3, NFocus Medical, David Fiorella Cordis, Micrus Endovascular. Stock/Shareholder: Vascular Simulators LLC Dawn S. Eliashiv Consultant/Advisor & Lecture fee - UCB and Lundbech Alcon/Novartis - Consultant/Advisor Merck - Grant support Donald J. Zack Allergan - Consultant/Advisor Johns Hopkins - Patents/Royalty University Grants/Research Support - NIH and DOD E. Mark Haacke Industry Grant Support - Siemens Medical Solution Edward Herskovits Grant Support: NIH and Microsoft, Consultant/Advisor: Bioclinca, * Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for educational services 6 10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image Guided Therapy May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy CONTINUING MEDICAL EDUCATION (CME) DISCLOSURE INFORMATION Name Type of Disclosures - What was Disclosed Grant Support: Allergan Ejaz Shamim Equity/Owner: Medtronic Inc ( own some stock) Other Financial or Material Support - Royalty payments related to Elizabeth Hillman ‘DYCE’ dynamic imaging method from MGH / PerkinElmer Other Financial or Material Support: Gerard Gioia Psychological Assessment Resources (PASR) Inc. (Patents/Royality), Impact Application Inc. (test author) University Grants/Research Support - VA Merit Review Grant Award J. Wesson Ashford Consultant Fee Grifols, Inc., Neurotez, Inc. University Grant/Research Support - NEUROPACE James Leiphart Employee - INOVA University Grant/Research Support: Neuren James M Ecklund Other Financial Support: President of a consulting company for gov- ernment and military relevant neurotrauma James Pekar Industry Grant Support: Phillips HealthCare, Inc. Other Financial or Material Support - None financially but I am co- James Welsh founder of Radion Global, a board member of Coqui Jane Tavyev Asher Research Support: Muscular Dystrophy Association Other Financial or Material Support - J.P.C and Washington University Joseph Culver have financial interests in Cephalogics LLC based on a license of re- lated optical imaging technology by the University to Cephalogics LLC. Joshua Medow BHR Pharma Project Trial Grant. Lee Martin Grant Support: Congenia Leonard A. Levin Consultant and Employee: Medtronic Inc. Maria Angela Franceschini University Grants/Research Support Canon USA, ISS Inc Stock or Shareholder - Founding member and Shareholder in NeuroVi- Maya Koronyo-Hamaoui sion Imaging LLC (NVI) Speaker’s Bureau - NVI Michael Wright Employee: Varian Medical Systems, Inc Mohan Vemuri Owns stock from the company (Life Tech) * Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for educational services elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.  7 10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image Guided Therapy May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy CONTINUING MEDICAL EDUCATION (CME) DISCLOSURE INFORMATION Name Type of Disclosures - What was Disclosed Consultant, Neuroelectrics Barcelona. This company produces toes Pedro Cavaleiro Miranda devices. Peter van Zijl Industry Grant Support: Philips Healthcare Stock or Shareholder - to-BBB holding BV (founder shares and stock Pieter Gaillard options) Employee [any industry] - to-BBB technologies BV (salary) Roger Little Stock or Shareholder - AstraZeneca (spouse) Stock or Shareholder and Employee: Rohan Fernandes Spouse Varnika Roy, Scientist I - MedImmune, LLC University Grant/Research Support: NIH, Am. Heart Assn., Research Ruikang K Wang for Prevention of Blindness Consultant Fee: Vistaon J&J Vison Prod. Inc Shattnath Merbs Consultant Fee: Spouse with Stryker University Grants/Research Support - Spouse: Research grants/ contracts through Johns Hopkins University Industry Grant Support - Spouse: Amgen, Avid Pharmaceuticals/Eli Susan Resnick Lilly, Biotie, Intracellular, Johnson and Johnson, Lundbeck, Roche Consultant Fee - Spouse: Consultant/Honoraria from Amgen Stock or Shareholder Honorarium - Spouse: Consultant/Honoraria from Amgen Industry Grant Support: Stryker, Audax, Consultant Fee: Nanovis Thomas Webster Stock or Shareholder: Nanovis, Audax Honorarium: International Journal of Nanomedicine Xingde Li Other Financial Support: Rotality payment from LightLab Imaging LLC Zachary T. Levine Consultant/Advisor and Employee: Medtronic Inc. Consultant/Advisor: Medtronic, IPSEN, MERZ, US World Meds Zoltan Mari Grant Support: Allergin, ABBOTT * Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for educational services elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.  8 10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image Guided Therapy May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy CONTINUING MEDICAL EDUCATION (CME) DISCLOSURE INFORMATION Alberto Bravin Jaydev Desai Nilesh Vyas Alexander Potapov Jean Paul Allain Panayiotis Sioutos Andrei Medvedev Jeff Elias Pantaleo Romanelli Andrew Degnan Jeff Teigler Paola Coan Andrew Dunn Jeffrey Chung Patricia Raksin Anindo Roy Jennifer L. Hopp Paul Pasquina Babak Kateb Jennifer Rusiecki Paul Patterson Beverly C. Walters Jim Smirniotopoulos Philip A. Defina Bizhan Aarabi John W. McDonald Pranav Vyas Carlos Pardo Jorge M. Serrador QingmingLuo Carol A. Miller Josep A. Planell Rasul Chaudhry Carson Smith Juan Jose Pavon Palacio Robert Lipsky Chandler Sours Juan Troncoso Robert Stern Codrin Ion Lungu Julie Chapman Robert W. Nickells Congwu Du Kaisorn L. Chaichana Roger Packer Craig Atwood Kareem A. Zaghloul Roger Packer Daniel C. Lee Katherine Warren Ronald Goodman Daniel E. Callan Keith Main Russel Lonser David Seminowicz Kenichi Oishi Shailesh Kantak Dongju Seo Kevin Crutchfield Shuo Chen Elaine Shen Kewal Jain Song Hu Eliot Siegel Kuldip Sidhu Stewart H. Mostofsky Elisabeth Schultke Laith Altaweel Sujit Prabhu Evgeny Tsimerinov Larry Forrester Susan Conroy Geoff Ling Ling Li Tao Lu Lowe Gilbert Vezina Lori Beason-Held Thom A. Mayer Graeme Woodworth Madhav Thambisetty Vassiliy Tsytsarev Guoying Liu Maheen Mausoof Adamson Vicky Yamamoto H. Ronald Zielke Manuel B. Datiles Visar Belegu Hanli Liu Martina Stippler Vivek Patel Hillard Lazarus Meenakshi Malhotra Waguih W. IsHak Jamie Grimes Michael J. Roy Xuemei Wang * Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for educational services elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.   9 10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image Guided Therapy May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy SOCIETY BOARD OF DIRECTORS     Kuldip Sidhu Babak Kateb, Michael J. Roy, Vice President, Chairman/CEO SBMT 9th President, SBMT & President of Brain SBMT Associate Professor, Stem Cell Director of Internal Medicine, Mapping Foundation USUHS, Arlington, Virginia Research, University of New       South Wales Michele R. Aizenberg Assistant Professor, Mitchel S. Berger Brain and Spine Can- Rafat Ansari Professor and Chair, Depart- cer Center University of Human Research Program ment of Neurological Surgery, NASA/ GRC Nebraska Medical Cen- UCSF       ter Benjamin Oliver Burt, Michael Y. Chen, Kirsty Duncan   Assistant professor of Oculoplastic   Associate Professor of De-   Member of Canadian Parlia- and Orbitofacial Surgery, Texas partment of Neurosurgery, ment; Tech University City of Hope Cancer Center Etobicoke, Canada Massimo S. Fian- daca Michael Fehlings Warren Grundfest Associate Professor, Re-       Professor, Department of Surgery, search Track, Professor of Surgery, UCLA University of Toronto Department of Neurology Geffen School of Medicine Georgetown University Medi- cal Center Lucien Levy Kian Kaviani Professor of Radiology and Robert Nickells Director Neuroradiology Professor of Electrical Engineering, Vice Chairman of Research,     Senior Editor, American Ming Hsieh Electrical Engineering UW Comprehensive Cancer Journal of Neuroradiology Dept., Viterbi School of Engineer- Center, Institute on Aging and George Washington Univer- ing the Eye Research Institute sity Medical Center, Wash-   ington, D.C. 10